Talk:BFAI
Add topicLatest comment: 1 year ago by 76.174.0.57
| This is the talk page for discussing improvements to the BFAI article. This is not a forum for general discussion of the subject of the article. |
Article policies
|
| Find sources: Google (books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL |
 | This article is rated Stub-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | |||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||
The name 5,6-Benzofuranyl-2-aminoindane isn't actually valid. See https://opsin.ch.cam.ac.uk/opsin/5,6-Benzofuranyl-2-aminoindane.png. Briefly, the benzene ring is incorrectly named as part of the indane ring system and the benzofuran ring system. See IUPAC name 6,7-Dihydro-5H-indeno[5,6-b]furan-6-amine/ FWIW /Steve Tillbury (talk) 02:06, 7 December 2023 (UTC)
- I noticed this too. Pinging User:Meodipt (the page's creator). – 76.174.0.57 (talk) 19:32, 7 December 2024 (UTC)
- Yes the name is not chemically correct. I saw this compound referred to as "BFAI" when people were discussing Tactogen's patent online, by analogy with the closely related MDAI, and thought it was a reasonable common name for it, but I agree this is inaccurate. What would you suggest for a more appropriate page name? In the patent it is just referred to as "Structure 1" which is not specific enough, and the proper chemical name is a bit long and cumbersome for a page name. Meodipt (talk) 19:49, 7 December 2024 (UTC)
- I see. That seems reasonable. It's probably fine to leave it as is for now. The name can be updated if or when another name is established. – 76.174.0.57 (talk) 05:45, 8 December 2024 (UTC)